These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 24030387)
1. Mast cells suppress murine GVHD in a mechanism independent of CD4+CD25+ regulatory T cells. Leveson-Gower DB; Sega EI; Kalesnikoff J; Florek M; Pan Y; Pierini A; Galli SJ; Negrin RS Blood; 2013 Nov; 122(22):3659-65. PubMed ID: 24030387 [TBL] [Abstract][Full Text] [Related]
2. Host natural killer T cells induce an interleukin-4-dependent expansion of donor CD4+CD25+Foxp3+ T regulatory cells that protects against graft-versus-host disease. Pillai AB; George TI; Dutt S; Strober S Blood; 2009 Apr; 113(18):4458-67. PubMed ID: 19221040 [TBL] [Abstract][Full Text] [Related]
3. Mast cells are required for phototolerance induction and scratching abatement. Schweintzger NA; Bambach I; Reginato E; Mayer G; Limón-Flores AY; Ullrich SE; Byrne SN; Wolf P Exp Dermatol; 2015 Jul; 24(7):491-6. PubMed ID: 25776520 [TBL] [Abstract][Full Text] [Related]
4. Chemokine (C-C motif) receptor 2 mediates mast cell migration to abdominal aortic aneurysm lesions in mice. Zhang J; Chen H; Liu L; Sun J; Shi MA; Sukhova GK; Shi GP Cardiovasc Res; 2012 Dec; 96(3):543-51. PubMed ID: 22871590 [TBL] [Abstract][Full Text] [Related]
5. Blockade of chronic graft-versus-host disease by alloantigen-induced CD4+CD25+Foxp3+ regulatory T cells in nonlymphopenic hosts. Giorgini A; Noble A J Leukoc Biol; 2007 Nov; 82(5):1053-61. PubMed ID: 17684039 [TBL] [Abstract][Full Text] [Related]
6. The role of recipient mast cells in acute and chronic cardiac allograft rejection in C57BL/6-KitW-sh/W-sh mice. Itoh S; Nakae S; Velotta JB; Kosuge H; Connolly A; Tsai M; Adachi H; Galli SJ; Robbins RC; Fischbein MP J Heart Lung Transplant; 2010 Apr; 29(4):401-9. PubMed ID: 19818646 [TBL] [Abstract][Full Text] [Related]
8. SHIP limits immunoregulatory capacity in the T-cell compartment. Collazo MM; Wood D; Paraiso KH; Lund E; Engelman RW; Le CT; Stauch D; Kotsch K; Kerr WG Blood; 2009 Mar; 113(13):2934-44. PubMed ID: 19136659 [TBL] [Abstract][Full Text] [Related]
9. CD4+ invariant natural killer T cells protect from murine GVHD lethality through expansion of donor CD4+CD25+FoxP3+ regulatory T cells. Schneidawind D; Pierini A; Alvarez M; Pan Y; Baker J; Buechele C; Luong RH; Meyer EH; Negrin RS Blood; 2014 Nov; 124(22):3320-8. PubMed ID: 25293774 [TBL] [Abstract][Full Text] [Related]
10. BET Bromodomain Inhibitors Which Permit Treg Function Enable a Combinatorial Strategy to Suppress GVHD in Pre-clinical Allogeneic HSCT. Copsel SN; Lightbourn CO; Barreras H; Lohse I; Wolf D; Bader CS; Manov J; Kale BJ; Shah D; Brothers SP; Perez VL; Komanduri KV; Wahlestedt C; Levy RB Front Immunol; 2018; 9():3104. PubMed ID: 30733722 [TBL] [Abstract][Full Text] [Related]
11. Interleukin-27 Enforces Regulatory T Cell Functions to Prevent Graft-versus-Host Disease. Le HT; Keslar K; Nguyen QT; Blazar BR; Hamilton BK; Min B Front Immunol; 2020; 11():181. PubMed ID: 32117306 [TBL] [Abstract][Full Text] [Related]
12. Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+CD25+Foxp3+ regulatory T cells. Shin HJ; Baker J; Leveson-Gower DB; Smith AT; Sega EI; Negrin RS Blood; 2011 Aug; 118(8):2342-50. PubMed ID: 21734238 [TBL] [Abstract][Full Text] [Related]
13. [Influence of donor T(reg) cells on GVHD and hematopoietic reconstitution after allogeneic bone marrow transplantation in mice]. Yang K; Liu QF; Fan ZP; Zhang Y Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):547-52. PubMed ID: 17605863 [TBL] [Abstract][Full Text] [Related]
14. Kit (W-sh) mice develop earlier and more severe experimental autoimmune encephalomyelitis due to absence of immune suppression. Li H; Nourbakhsh B; Safavi F; Li K; Xu H; Cullimore M; Zhou F; Zhang G; Rostami A J Immunol; 2011 Jul; 187(1):274-82. PubMed ID: 21646293 [TBL] [Abstract][Full Text] [Related]
15. Host Foxp3+CD4+ Regulatory T Cells Act as a Negative Regulator of Dendritic Cells in the Peritransplantation Period. Inoue T; Ikegame K; Kaida K; Okada M; Yoshihara S; Tamaki H; Fujimori Y; Soma T; Ogawa H J Immunol; 2016 Jan; 196(1):469-83. PubMed ID: 26621858 [TBL] [Abstract][Full Text] [Related]
16. Rorc restrains the potency of ST2+ regulatory T cells in ameliorating intestinal graft-versus-host disease. Yang J; Ramadan A; Reichenbach DK; Loschi M; Zhang J; Griesenauer B; Liu H; Hippen KL; Blazar BR; Paczesny S JCI Insight; 2019 Mar; 4(5):. PubMed ID: 30694220 [TBL] [Abstract][Full Text] [Related]
17. Mast cell-derived TNF can exacerbate mortality during severe bacterial infections in C57BL/6-KitW-sh/W-sh mice. Piliponsky AM; Chen CC; Grimbaldeston MA; Burns-Guydish SM; Hardy J; Kalesnikoff J; Contag CH; Tsai M; Galli SJ Am J Pathol; 2010 Feb; 176(2):926-38. PubMed ID: 20035049 [TBL] [Abstract][Full Text] [Related]
18. Induced regulatory T cells promote tolerance when stabilized by rapamycin and IL-2 in vivo. Zhang P; Tey SK; Koyama M; Kuns RD; Olver SD; Lineburg KE; Lor M; Teal BE; Raffelt NC; Raju J; Leveque L; Markey KA; Varelias A; Clouston AD; Lane SW; MacDonald KP; Hill GR J Immunol; 2013 Nov; 191(10):5291-303. PubMed ID: 24123683 [TBL] [Abstract][Full Text] [Related]
19. Recipient type-specific engineered regulatory T cells prevent graft-vs-host disease after allogeneic bone marrow transplantation in mice. Chen C; Cao J; Zeng L; Li Y; Wang D; Xu K Transplant Proc; 2011 Jun; 43(5):2041-8. PubMed ID: 21693322 [TBL] [Abstract][Full Text] [Related]
20. Peanut-induced intestinal allergy is mediated through a mast cell-IgE-FcepsilonRI-IL-13 pathway. Wang M; Takeda K; Shiraishi Y; Okamoto M; Dakhama A; Joetham A; Gelfand EW J Allergy Clin Immunol; 2010 Aug; 126(2):306-16, 316.e1-12. PubMed ID: 20624645 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]